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Abstract
Background: Streptococcus pneumoniae is a human pathogenic bacteria and a major cause of severe
invasive diseases, including pneumonia, bacteremia, and meningitis. Infections with S. pneumoniae
evoke a strong inflammatory response, which plays a major role in the pathogenesis of
pneumococcal disease.
Results: In this study, we have examined how S. pneumoniae affects expression of the inflammatory
cytokine tumor necrosis factor (TNF) α, and the molecular mechanisms involved. Secretion of
TNF-α was strongly induced by S. pneumoniae, which was able to stabilize TNF-α mRNA through
a mechanism dependent on the viability of the bacteria as well as the adenylate uridylate-rich
elements in the 3'untranslated region of TNF-α mRNA. The ability of S. pneumoniae to stabilize
TNF-α mRNA was dependent on the mitogen-activated protein kinase (MAPK) p38 whereas
inhibition of Toll-like receptor signaling via MyD88 did not affect S. pneumoniae-induced mRNA
stabilization. P38 was activated through a pathway involving the upstream kinase transforming
growth factor-activated kinase 1 and MAPK kinase 3.
Conclusion: Thus, S. pneumoniae stabilizes TNF-α mRNA through a pathway dependent on p38
but independent of Toll-like receptors. Production of TNF-α may contribute significantly to the
inflammatory response raised during pneumococcal infection.
Background
Streptococcus pneumoniae is an important cause of severe
invasive infections, including pneumonia, bacteremia,
and meningitis [1,2]. Nasopharyngeal carriage of S. pneu-
moniae is common among children, but in most cases bac-
terial invasion into the lungs or bloodstream is prevented
by local host defenses in the upper airways [3]. However,
in a minority of individuals, pneumocooci gain access to
deeper structures of the body and thereby cause invasive
disease [3], which are almost uniformly fatal if not treated
with antibiotics. Even in the presence of appropriate treat-
ment, invasive pneumococcal disease bears a relatively
poor prognosis [4]. Pneumococci are known to elicit a
very potent inflammatory response [1,5], a key compo-
nent of which is the production of cytokines and chemok-
ines, which participate in the elimination of bacteria but
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may also result in undesirable excessive immunological
responses, which may be harmful to the host [1].
The cytokine tumor necrosis factor (TNF)-α is produced
by macrophages and dendritic cells as a primary response
to infections and tissue damage, and is constitutively
expressed in several autoimmune diseases [6]. TNF-α
plays an important role in activation and recruitment of
leukocytes to inflamed tissue [6], and has been demon-
strated to be involved in the host-defense against a
number of important human pathogens, including S.
pneumoniae [7-9]. However, TNF-α is also associated with
excessive inflammation and immunopathology in infec-
tions and autoimmune diseases, and specifically, TNF-a
has been suggested to be involved in breakage of the
blood-brain barrier during development of hematoge-
nous pneumococcal meningitis [10].
Production of TNF-α is regulated both at the level of tran-
scription, mRNA stability, and translation [11-13]. The
regulation of mRNA stability and translation is mediated
largely through adenylate uridylate (AU)-rich elements
(ARE)s present in the 3'-untranslated region (UTR) of
mRNA, which are targeted by ARE-binding proteins able
to affect mRNA stability and translation [13,14]. The
importance of AREs in regulation of TNF-α production is
evidenced by spontaneous development of chronic
inflammatory arthritis and Crohn's-like inflammatory
bowel disease in transgenic mice devoid of AREs in mRNA
encoding TNF-α [12].
The inflammatory response to infection is triggered by
pattern recognition receptors (PRR)s, which recognize
evolutionarily conserved pathogen-associated molecular
patterns (PAMP)s and activate intracellular signaling,
thereby up-regulating expression of genes with inflamma-
tory activities, including TNF-α [15]. The Toll-like recep-
tors (TLR)s constitute an important class of PRRs, and
TLR2, 4, and 9 have been shown to recognize pneumococ-
cal PAMPs [3,16-20]. The vast majority of TLR down-
stream signaling proceeds through the cytoplasmic
adaptor protein MyD88, which is central for activation of
the transcription factor nuclear factor (NF) κB, and the
mitogen-activated protein kinase (MAPK) pathway, being
involved in both transcriptional and post-transcriptional
responses [21]. However, several studies suggest that
pneumococcal recognition and pathogenesis may be at
least partly independent of TLR signaling [22,23]. Another
class of PRRs involved in recognition of S. pneumoniae is
the nucleotide-binding oligomerization domain (NOD)
proteins, which are intracellular PRRs [24]. The NOD2
protein recognizing muramyl dipeptide has been reported
to be important for activation of NF-κB during infection
with S. pneumoniae [25].
In this study, we have investigated the role of mRNA sta-
bilization in TNF-α production induced by S. pneunomiae,
including the signaling mechanisms involved. Here we
report that live S. pneunomiae strongly stabilizes TNF-α
mRNA by a mechanism dependent on the AREs in the 3'-
UTR of the mRNA. Importantly, increased TNF-α mRNA
stability induced by S. pneunomiae was not mediated by
TLRs but was dependent on the p38 MAPK, which was
activated through a pathway involving transforming
growth factor-activated kinase (TAK) 1 and MAPK kinase
(MKK) 3.
Results
S. pneumoniae induces TNF-α production and stabilizes 
TNF-α mRNA through AREs in the 3'-UTR
Given the important role of the inflammatory response in
the pathogenesis of streptococcal diseases [1], we were
interested in studying mechanisms involved in expression
of inflammatory cytokines during infection with S. pneu-
moniae. In a first set of experiments, we measured expres-
sion of TNF-α in murine macrophages after treatment
with S. pneumoniae, N. meningitidis or pure ligands for
TLR2 (Pam3Csk4), TLR4 (LPS), and TLR9 (ODN1826).
As expected, cells responded to addition of bacteria or TLR
ligands by secreting high amounts of TNF-α (Fig. 1A). LPS
has been reported to stimulate TNF-α expression by both
activating gene transcription, stabilizing the TNF-α
mRNA, and supporting translation [11-13]. To examine
whether  S. pneumoniae stabilized TNF-α mRNA, we
treated cells with actinomycin D, which prevents de novo
transcription of mRNA, and stimulated the macrophages
with S. pneumoniae, N. meningitidis or LPS. At the indi-
cated time-points post-stimulation, RNA was harvested
and TNF-α mRNA levels were determined by real-time
PCR. As shown in Fig. 1B, addition of actinomycin D led
to a rapid decline in the levels of remaining TNF-α mRNA
in cells receiving mock treatment. However, treatment
with S. pneumoniae profoundly augmented the half-life of
TNF-α mRNA (from about 30 min to about 6 hours). LPS
and N. meningitidis also stabilized the TNF-α messenger
but not to the same extent as S. pneumoniae. To examine
whether the AREs of the TNF-α mRNA were required for
the observed effect, we turned to a cell system derived
from RAW264.7 cells, consisting of two cell lines stably
expressing a reporter gene (chloramphenicol acetyl trans-
ferase, CAT), transcribed from a constitutive promoter. In
one of the cell lines (RAW TNF-α 3'-UTR AU+) the 3'-UTR
of the mRNA encoding the reporter gene is derived from
the wild-type TNF-α mRNA, and in the other cell line
(RAW TNF-α 3'-UTR AU÷) the AREs of the TNF-α 3'-UTR
are mutated. When the RAW TNF-α 3'-UTR AU+ cell line
was incubated in the presence of S. pneumoniae, a very
strong increase in CAT levels was observed (Fig. 1C),
whereas LPS and also N. meningitidis affected accumula-
tion of CAT protein only to a more modest extent. Inter-BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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estingly, the effect of S. pneumoniae on accumulation of
CAT was largely abrogated in the RAW TNF-α 3'-UTR AU÷
cell line. Thus, S. pneumoniae stimulates production of
TNF-α and stabilizes TNF-α mRNA through a mechanism
involving the AREs in the 3'-UTR of the mRNA.
Stabilization of TNF-α mRNA by S. pneumoniae is 
dependent on the viability of the bacteria
We next examined the pneumococcal requirement for
mediating TNF-α mRNA stability. To this end, we com-
pared the ability of live versus killed bacteria to induce
CAT expression in the RAW TNF-α 3'-UTR AU+/AU- cell
lines (Fig. 2A and 2B). As also shown in Fig. 1C, S. pneu-
moniae  induced accumulation of CAT, and this was
dependent on the 3'-UTR AREs (Fig. 2). Interestingly, S.
pneumoniae killed either by heat-inactivation, UV light or
penicillin displayed reduced ability to induce CAT expres-
sion, with the reduction ranging from almost 100% (heat-
inactivated bacteria) to about 65% (penicillin-killed bac-
terial). Thus, stabilization of TNF-α mRNA by S. pneumo-
niae is dependent on the viability of the bacteria.
S. pneumoniae mediates TNF-α mRNA stability 
independent of TLRs
The S. pneumoniae SK1013 strain used in this study has
previously been demonstrated to be recognized by TLR2
and 9 [16], with the former recognizing bacterial pepti-
doglycan and lipoteichoic acid and the latter recognizing
bacterial DNA [16-18,26]. We have previously demon-
strated that TLR9 recognizes live but not heat-killed S.
pneumoniae  [16] wherefore the data shown in Fig. 2
prompted us to examine the role of TLR9 in stabilization
Figure 1
S. pneumoniae induces TNF-α production and stabilizes TNF- α mRNA through AREs in the 3'-UTR Figure 1
S. pneumoniae induces TNF-α production and stabi-
lizes TNF-α mRNA through AREs in the 3'-UTR. (A) 
C57BL/6 macrophages were stimulated with vehicle, S. pneu-
moniae, N. meningitidis (5 × 107 bacteria/ml), LPS (100 ng/ml), 
Pam3Csk4 (200 ng/ml), or ODN1826 (1 μM). Supernatants 
were harvested 18 h later, and TNF-α was measured by 
ELISA. (B) C57BL/6 macrophages were treated with 1 μM 
actinomycin D 15 min prior to treatment with vehicle, S. 
pneumoniae, N. meningitidis (both 5 × 107 bacteria/ml), or LPS 
(100 ng/ml). The cells were lysed at the indicated time points 
and Total RNA was harvested. TNF-α and β-actin mRNAs 
were detected by qPCR, and normalized ratios were calcu-
lated. The data is shown as percent remaining TNF-α mRNA 
compared to untreated control. (C) RAW-TNF-AU+ and 
RAW-TNF-AU÷ cells were seeded and treated with vehicle, 
S. pneumoniae, N. meningitidis (both 5 × 107 bacteria/ml), or 
LPS (100 ng/ml). Total cell lysates were harvested 20 h later 
and CAT was measured by ELISA. Similar results were 
obtained in 2–4 independent experiments. The data are 
shown as means +/- SEM.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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of TNF-α mRNA. We first examined how pure TLR ago-
nists affected CAT expression in the RAW-TNF-α 3'-UTR
AU+ cell line and compared this with the response evoked
by live S. pneumoniae. The agonists for TLR2, 4, and 9 all
enhanced CAT expression but to a rather moderate extent
compared to what was observed in cells receiving live S.
pneumoniae (Fig. 3A). To directly assess the role of TLR9,
we treated cells with the TLR9 antagonist ODN2088 prior
to addition of S. pneumoniae and measured CAT expres-
sion in lysates at later time points. Although ODN2088
inhibited induction of TNF-α by the TLR9 agonist
ODN1826 by more than 95% (data not shown), the pres-
ence of the TLR9 antagonist had no effect on CAT expres-
sion induced by S. pneumoniae (Fig. 3B), thus suggesting
that mRNA stabilization by S. pneumoniae is independent
of TLR9.
To more broadly examine the role of TLRs in stabilization
of TNF-α mRNA during S. pneumoniae infection, we pre-
treated cells with a cell-permeable MyD88 inhibitory pep-
tide or an inactive control peptide prior to addition of
bacteria. However, this treatment did not affect S. pneumo-
niae-induced CAT expression (Fig. 3C), although the
inhibitory peptide did indeed inhibit TLR signaling both
strongly and specifically (Fig. 3D). Thus, the ability of S.
pneumoniae to stabilize TNF-α mRNA seems to be inde-
pendent of bacterial signaling through TLRs.
Stabilization of TNF-α mRNA by S. pneumoniae is dependent  on the viability of the bacteria Figure 2
Stabilization of TNF-α mRNA by S. pneumoniae is 
dependent on the viability of the bacteria. RAW-TNF-
AU+ and RAW-TNF-AU÷ cells were seeded and treated 
with vehicle, live pneumoniae (5 × 107 bacteria/ml), or LPS 
(100 ng/ml) as well as bacteria (5 × 107 bacteria/ml) killed by 
either (A), heat, UV, or (B) penicillin treatment. Total cell 
lysates were harvested 20 h later and CAT was measured by 
ELISA. The data is shown as means +/- SEM. Similar results 
were obtained in 2–3 independent experiments.
S. pneumoniae mediates TNF-α mRNA stability independent  of TLRs Figure 3
S. pneumoniae mediates TNF-α mRNA stability inde-
pendent of TLRs. (A) RAW-TNF-AU+ cells were treated 
with vehicle, S. pneumoniae (5 × 107 bacteria/ml), LPS (100 ng/
ml), Pam3Csk4 (200 ng/ml), or ODN1826 (1 μM). Total cell 
lysates were harvested 20 h later and CAT was measured by 
ELISA. (B) RAW-TNF-AU+ cells were treated with the TLR9 
antagonist ODN2088 (3 μM) 15 min prior to addition of 
vehicle or S. pneumoniae (5 × 107 bacteria/ml) to the cell cul-
tures. Total cell lysates were harvested 20 h later and CAT 
was measured by ELISA. (C and D) RAW-TNF-AU+ cells 
were treated with a MyD88 inhibitor peptide or a control 
peptide for 24 h before addition of (C) vehicle or S. pneumo-
niae (5 × 107 bacteria/ml) or (D) LPS (100 ng/ml) or TNF-α 
(25 ng/ml) plus IFN-γ (10 ng/ml). (C) Total cell lysates were 
harvested 20 h later and CAT was measured by ELISA. (D) 
Supernatants were harvested 36 h post stimulation, and 
nitrite was measured by Griess assay. Similar results were 
obtained in 2–3 independent experiments. The data are 
shown as means +/- SEM.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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P38 MAPK is important for stabilization of TNF-α mRNA 
by S. pneumoniae
The signaling pathways responsible for mediating mRNA
stability have recently been studied extensively, and it
appears that P38 MAPK plays a central role in this process
[13]. To examine the role of p38 in stabilization of TNF-α
mRNA in response to S. pneumoniae infection, we treated
the RAW TNF-α 3'-UTR AU+ cell line with the p38 inhib-
itor SB202190 15 min prior to addition of S. pneumoniae.
CAT was subsequently measured in cell lysates. As shown
in Fig. 4A, the strong elevation of CAT protein levels
observed after infection with live S. pneumoniae was signif-
icantly inhibited by the presence of SB202190. It has been
reported that the p38 MAPK inhibitor SB203580, which is
structurally very similar to SB202190, not only inhibits
p38 but also the kinase receptor-interacting protein (RIP)
2 [27], which plays an important role in signaling down-
stream of the S. pneumoniae-activated PRR NOD2 [27].
Therefore, we also examined the effect of another RIP2
inhibitor, PP2 [27], on induction of CAT protein in our
reporter system However, as illustrated in Fig. 4A, no
effect of PP2 treatment towards bacteria-induced CAT pro-
duction was observed.
In Fig. 2 we demonstrated that live but not heat-killed S.
pneumoniae  mediated stabilization of TNF-α mRNA.
Therefore, we hypothesized that live versus heat-killed S.
pneumoniae  may differentially activate p38. RAW264.7
cells were stimulated with live or heat-killed S. pneumoniae
for the indicated time intervals, whole-cell lysates were
harvested and the levels of phosphorylated p38 were
measured. Indeed, the results showed that live bacteria
potently stimulated phosphorylation of p38, heat-killed
bacteria were not able to elicit such a response (Fig. 4B).
To more thoroughly study the role of p38 in S. pneumo-
niae-mediated mRNA stabilization, we wanted to examine
how inactivation of TLR signaling, which did not affect
TNF-α mRNA stabilization (Fig. 3), might influence p38
activation. Therefore, we pretreated RAW264.7 cells and
primary macrophages with the MyD88 inhibitory peptide
or an inactive control peptide prior to addition of S. pneu-
moniae. The cells were lysed 30 min post-infection and lev-
els of phospho-p38 were measured. In both cell types we
observed strong activation of p38 in response to S. pneu-
moniae treatment and this was independent of the pres-
ence of the MyD88 inhibitory peptide (Fig. 4C and 4D).
Thus, stabilization of TNF-α mRNA by S. pneumoniae is
dependent on p38, and this kinase is activated by live bac-
teria through a mechanism independent of TLRs.
P38 mediates mRNA stabilization in response to S. 
pneumoniae independently of the MAPK-activated 
protein kinases MK2, MSK1/2, and MNK
P38-mediated mRNA stabilization can occur through sev-
eral mechanisms, including involvement of members of
the MAPK-activated protein kinase family, in particular
MK2 [28-30]. To examine the role of this family of kinases
in stabilization of TNF-α mRNA, we compared macro-
phages from C57BL/6 versus MK2-/- or MSK1/2-/- mice
with respect to stabilization of endogenous TNF-α mRNA
after challenge with S. pneumoniae. Furthermore, we also
examined the effect of the Mnk inhibitor CGP57380 on
production of CAT protein in the reporter cell line system.
In all cases, no role for the MAPK-activated protein
kinases was found (data not shown).
Activation of p38 MAPK in response to S. pneumoniae is 
dependent on TAK1 and involves MKK3
In order to gain more insight into the mechanism of p38
activation during infection with S. pneumoniae, we first
examined the role of TAK1, which has been ascribed an
important role in this process by activating a number of
different pathways [31-33]. RAW264.7 cells were seeded
and treated with the TAK1 inhibitor (5Z)-7-oxozeaenol
15 min prior to stimulation with S. pneumoniae or ani-
somycin. Lysates were prepared 30 min post-stimulation,
and levels of phospho-p38 were measured. As shown in
Fig. 5A, both S. pneumoniae and anisomycin potently
induced phosphorylation of p38. Whereas the TAK1
inhibitor did not affect activation of p38 in response to
anisomycin, the ability of S. pneumoniae to induce p38
phosphorylation was abolished in the presence of the
TAK1 inhibitor.
MKK3, as well as MKK4, and 6 are p38 upstream kinases
and can be activated through TAK1 [34]. To evaluate the
role of MKK3 in the S. pneumoniae-induced p38 activation
pathway, we compared the ability of spleen cells from
C57BL/6 and MKK3-/- mice to activate p38 in response to
S. pneumoniae treatment. Anisomycin was included as a
control, and was found to trigger p38 activation inde-
pendently of MKK3 (Fig. 5B). By contrast, MKK3-/- cells
responded to S. pneumoniae with significantly reduced,
although not abolished, activation of p38. Taken together,
these data demonstrate that S. pneumoniae activates p38
through a TLR-independent pathway involving the
upstream kinases TAK1 and MKK3.
Discussion
In this work we demonstrate that S. pneumoniae mediates
stabilization of TNF-α mRNA in macrophages by a mech-
anism dependent on the AREs in the 3'-UTR of TNF-α
mRNA. The pathway stimulating this mechanism is inde-
pendent of TLR signaling and involves TAK1, MKK3, and
p38 MAPK.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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P38 MAPK is important for stabilization of TNF-α mRNA by S. pneumoniae Figure 4
P38 MAPK is important for stabilization of TNF-α mRNA by S. pneumoniae. (A) RAW-TNF-AU+ cells were treated 
with the inhibitors SB202190 (p38 and RIP2) (5 μM) and PP2 (Src and RIP2) (500 nM) 15 min prior to addition of vehicle or S. 
pneumoniae (5 × 107 bacteria/ml) to the cell cultures. Total cell lysates were harvested 20 h later and CAT was measured by 
ELISA. The data is shown as means +/- SEM. (B) RAW264.7 cells were treated with live or heat-killed S. pneumoniae (5 × 107 
bacteria/ml) for the indicated amount of time, and whole cell lysates were isolated. Phosphorylation of p38 was measured by 
Luminex. The data is shown as means +/- SEM. (C and D) RAW264.7 (C) and C57BL/6 macrophages (D) were incubated with 
a MyD88 inhibitor peptide or a control peptide for 24 h before addition of vehicle or S. pneumoniae (5 × 107 bacteria/ml). 
Whole cell lysates were harvested 30 min later and phosphorylation of p38 was measured by Luminex. The data is shown as 
means +/- SEM. Similar results were obtained in 2–3 independent experiments.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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An important finding of this work is that recognition sys-
tems independent of TLRs are responsible for triggering S.
pneumoniae-induced signal transduction leading to stabili-
zation of TNF-α mRNA. Here we did not identify an alter-
native PRR responsible for activating the p38-dependent
signal. It has been reported that S. pneumoniae is recog-
nized by NOD2, which does indeed signal to p38 [24].
However, since inactivated S. pneumoniae should retain
the capacity to activate NOD2, and we found that the
RIP2 inhibitor PP2 did not affect expression of the CAT
reporter, our data suggest that the observed stabilization
of TNF-α mRNA by live S. pneumoniae does not depend on
NOD2. In addition, there is evidence that other receptor
systems may be involved in shaping the inflammatory
cytokine response during bacterial infections. For
instance, it has been reported that Borrelia burgdorferi can
induce intracellular signaling and inflammatory gene
expression independent of TLRs through direct binding to
integrin α3 and β1 [35].
The present finding of only live S. pneumoniae being able
to induce TNF-α mRNA stability suggests that a product or
activity of the bacterial life cycle is required to trigger the
p38-dependent signal mediating mRNA stability. Similar
findings have been previously reported for other bacteria,
since Kumar et al. demonstrated that live as opposed to
heat-killed  Staphylococcus aureus were able to stimulate
phosphorylation of the MAPKs p38 and JNK, as well as
the NF-κB inhibitory protein IκB [36]. In that study, how-
ever, the effects of live bacteria may have been attributable
to bacterial exoproducts, since the conditioned medium
of S. aureus also stimulated the signalling pathways [36].
The ability of S. pneumoniae to induce mRNA stabilization
was abrogated in the presence of the p38 MAPK inhibitor
SB202190, suggesting a role for this kinase. In addition,
the signaling pathway to p38 was entirely dependent on
TAK1 and partially dependent on MKK3. P38 MAPK is a
well-described mediator of mRNA stabilization affecting
the activity of a number of ARE-binding proteins [13,37].
For instance, p38 activates the kinase MK2, which phos-
phorylates tristetraprolin (TTP), an ARE-binding protein
with mRNA-destabilizing activity [28]. This phosphoryla-
tion event decreases the ARE affinity of TTP, hence leading
to increased mRNA stability. Another mechanism
involves HuR, which is induced by P38 MAPK and binds
to the AREs, thus stabilizing TNF-α mRNA [29,30]. In this
work we did not systematically investigate the molecular
mechanism of mRNA stabilization in response to S. pneu-
moniae infection, although we did find that it was inde-
pendent of the MAPK-activated protein kinases MK2,
MSK1/2, and MNK.
Conclusion
Here we report that live S. pneumoniae stabilizes TNF-α
mRNA and that this is dependent on the AREs in the 3'-
UTR of the mRNA. The bacteria-induced signals mediat-
ing this function were not transduced from TLRs but were
dependent on the p38 MAPK, the upstream activation of
which was dependent on TAK1 and MKK3. Given the
important role of TNF-α in the inflammatory response,
the present study provides new insight into the mecha-
nisms that govern production of inflammatory mediators
in macrophages during pneumococcal infection.
Activation of p38 MAPK in response to S. pneumoniae is  dependent on TAK1 and involves MKK3 Figure 5
Activation of p38 MAPK in response to S. pneumoniae 
is dependent on TAK1 and involves MKK3. (A) 
RAW264.7 cells were seeded in triplicate cultures and left 
overnight to settle. Fifteen min prior to stimulation, some 
wells received 1 μM of (5Z)-7-oxozeaenol. The cells were 
stimulated with S. pneumoniae (5 × 107 bacteria/ml) or ani-
somycin (100 ng/ml) for 30 min, and whole-cell lysates were 
prepared. (B) Spleen cells from C57BL/6 and MKK3-/- mice 
were seeded in triplicates and left overnight to settle. The 
cells were stimulated with S. pneumoniae (5 × 107 bacteria/
ml) or anisomycin (100 ng/ml) for 30 min, and whole-cell 
lysates were prepared. Phosphorylation of p38 MAPK was 
measured by Luminex, and data is presented as means +/- 
SEM. Similar results were obtained in 2 independent experi-
ments.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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Methods
Mice and cells
C57BL/6, MK2-/-, MSK1/2-/-, MKK3-/- mice were
obtained from Taconic (Laven, Denmark), professor
Mathias Gaestel (Hannover, Germany), professor Simon
Arthur (Dundee, UK), and professor Richard A Flavell
(Yale, USA), respectively, and bred in the animal facility of
The Faculty of Health Sciences, University of Aarhus,
under pathogen-free conditions. Peritoneal macrophages
were harvested by lavage of the peritoneal cavity with PBS
supplemented with 5% LPS-free heat-inactivated fetal calf
serum (FCS) (Cambrex, Baltimore, MD, USA) and 400 μl
heparin (Leo Pharma, Copenhagen, Denmark) per 100
ml. RAW264.7 macrophage-like cells and the derived cell
lines RAW TNF-α 3' untranslated region (UTR) AU+ and
RAW TNF-α 3'UTR AU÷ [38-40] were maintained in
DMEM supplemented with 5% FCS, antibiotics and for
the latter 2 cell lines also with 500 μg/ml G418 (Roche,
Basel, Switzerland). For experiments, primary macro-
phages were seeded in 96-well or 6-well tissue plates in
RPMI 1640 medium containing 5% FCS at a density of 3.0
× 105and 6.0 × 106 cells per well, respectively. RAW264.7
and derived cell lines were seeded in 96-well or 6-well tis-
sue plates at a density of 1.0 × 105 and 6.0 × 106 cells per
well, respectively. After seeding, cells were left overnight
to settle before further treatment.
Bacteria
The bacteria used were the S. pneumoniae strain SK1013
serotype 4 (TIGR4) and the N. meningitidis strain NGO93
serogroup B, serotype 15:P1.2, MLEE cluster I1, ET76. The
bacteria were grown overnight in Brain Heart Infusion
broth with 10% Levinthal broth (Statens Serum Institute,
Copenhagen) reaching a concentration of 18.0 ± 2.2 × 108
bacteria per ml as determined in a Thoma counting cham-
ber. For stimulation, 300 μl and 10 μl from this stock was
added to the cell cultures in 6- and 96-well plates, respec-
tively, reaching final volumes of 3 ml and 100 μl, respec-
tively. The bacteria were heat-inactivated by incubation of
the cultures for 30 min at 65°C. To UV-inactivate the bac-
teria, the cultures were exposed to UV light for 10 min,
and for killing of bacteria with penicillin, the cultures
were incubated for 2 h with 1.0 μg/ml of the antibiotics.
Reagents
The TLR agonists Pam3Csk4, LPS, and ODN1826 as well
as the TLR9 antagonist ODN2088 were obtained from
InvivoGen (San Diego, CA, USA). The MyD88
Homodimerization Inhibitory Peptide was purchased
from IMGENEX (San Diego, CA, USA). Actinomycin D,
anisomycin, SB202190, and PP2 were from Calbiochem
(San Diego, CA, USA). The TAK1 inhibitor (5Z)-7-oxoze-
aenol was purchased from AnalytiCon Discovery GmbH.
The cytokines TNF-α, and interferon (IFN)-γ were from
R&D Systems (Minneapolis, MN, USA). The Mnk inhibi-
tor CGP57380 was kindly provided by Hermann Gram
(Novatis).
TNF-α ELISA
For measurement of TNF-α. an ELISA duoset from R&D
Systems was used, following recommendations of the
manufacturer. The concentrations of coating Ab and
detection Ab were 0.8 and 0.15 mg/ml, respectively. The
ELISA was able to detect TNF-α from 15 to 2000 pg/ml.
Purification of RNA and Real-time PCR
Total RNA was extracted with TRIzol (Invitrogen,
Carlsbad, CA, USA) according to the recommendations of
the manufacturer. Briefly, cells were lysed in TRIzol, and
chloroform was added, followed by phase separation by
centrifugation. RNA was precipitated with isopropanol
and pelleted by centrifugation. Pellets were washed with
80% ethanol and re-dissolved in RNase-free water. For
cDNA generation, 1 μg of RNA was subjected to reverse
transcription (RT) with oligo(dT) as primer and Expand
Reverse Transcriptase (both from Roche). Prior to RT-
PCR, RNA was treated with DNase I (Ambion, Austin, TX,
USA) to remove any contaminating DNA, the absence of
which was confirmed in control experiments where the
reverse transcriptase enzyme was omitted (data not
shown). To measure the relative amount of TNF-α
mRNAs, amplification of sample cDNA was monitored
with the fluorescent DNA binding dye SYBR (QIAGEN).
The PCR primers used in this study were: TNF-forward,
TGGGAGTAGACAAGGTACAACCC; TNF-reverse, AGAG-
GGAAATCGTGCGTGAC;  β-actin-forward, GCTCCCCG-
GGCTGTATTCC; β-actin-reverse, CTCTCTTGCTCTGGG
CCTCGT). The data on TNF-α were normalized to β-actin,
and presented as normalized ratio.
Measurement of CAT levels
The cells were seeded and treated as described for the
appropriate amount of time. For cell lysis and measure-
ment of CAT levels the CAT ELISA kit from Roche (Basel,
Switzerland) was used.
Preparation of whole cell extracts
To assay for levels of total and phosphorylated p38, cells
were seeded in 6-well plates as described above and stim-
ulated with bacteria as specified in the text. At different
time points post-stimulation, cells were lysed using the
Bio-Plex Cell Lysis Kit (Bio-Rad, Hercules, CA, USA)
according to the recommendations of the manufacturer.
Briefly, the cells were washed with 3 ml Cell Wash Buffer
per well and treated with 1 ml Lysing Solution supple-
mented with PMSF followed by incubation for 20 min at
4°C. The suspension was centrifuged at 4500 × g for 20
min at 4°C and supernatants were harvested as whole-cell
extracts.BMC Immunology 2008, 9:52 http://www.biomedcentral.com/1471-2172/9/52
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Luminex
The levels of total and phosphorylated p38 were meas-
ured using the Luminex Technology™ and kits purchased
from Bio-Rad. Briefly, the filter plate was washed with
assay buffer and freshly vortexed antibody-conjugated
beads were added to each well. The plate was washed with
assay buffer and samples (45 μg of protein in 50 μl lysis
buffer) were added. After a brief shake (30 sec at 1.100
rpm), the plate was incubated with shaking (300 rpm)
overnight at 4°C. After a wash-step, detection antibody
was added to each well, and the plate was shaken and
incubated shaking (300 rpm) at room-temperature in the
dark for 45 min to 2 h. Subsequently, the plate was
washed and incubated for 10 min with 50 μl of a strepta-
vidine-PE solution with shaking (30 sec at 1.100 rpm, 10
min 300 rpm). Finally the plate was washed and 125 μl of
assay buffer was added to each well and the plate was
shaken for 10 sec at 1100 rpm and read immediately on
the Bio-Plex reader.
Nitrite determination
Nitrite is generated by the rapid oxidation of NO. It is sta-
ble and its accumulation in the culture medium reflects
the amount of NO produced. To assay nitrite we used the
Griess reaction. Aliquots of 100 μl culture supernatants
were mixed with equal volumes of Griess reagent (equal
volumes of 0.1% N-(1-naphthyl)-ethylenediamine dihy-
drochloride and 1% p-aminobenzene sulphanilamide
diluted in 2.5% phosphoric acid) in a 96-well microtitre
plate (Maxisorb Immunoplate, Nunc). After 10 min incu-
bation at room temperature the absorbance at a wave-
length of 540 nm was measured in a microplate reader
(model 450; Bio-Rad). A range of 2-fold dilutions of
sodium nitrite (0.05 to100 μM) in RPMI medium was run
in each assay to generate a standard curve. In most exper-
iments, control cultures not infected or stimulated gave
small nitrite values in the order of 0–1 μM. These figures
were subtracted from the experimental values in the data
presentation.
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